Boehringer Ingelheim· @Boehringer · X·· 2026-06-08AI 评分42
AI 导读
#NEWS：两项针对肥胖人群的III期试验完整数据在#ADA2026上公布。 这些结果显示出满足肥胖及肝脏健康领域患者未满足需求的潜力。 阅读更多 👉 https://go.boehringer.com/MYA #LifeForward #ADASciSessions
正文
#NEWS: Full data from two Phase III trials in people living with #obesity presented at #ADA2026.
These results show potential to address patients’ unmet needs in obesity and liver health.
Read more 👉 https://go.boehringer.com/MYA
#LifeForward #ADASciSessions
来源：Boehringer Ingelheim · x.com